[go: up one dir, main page]

DE69928685D1 - Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit - Google Patents

Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit

Info

Publication number
DE69928685D1
DE69928685D1 DE69928685T DE69928685T DE69928685D1 DE 69928685 D1 DE69928685 D1 DE 69928685D1 DE 69928685 T DE69928685 T DE 69928685T DE 69928685 T DE69928685 T DE 69928685T DE 69928685 D1 DE69928685 D1 DE 69928685D1
Authority
DE
Germany
Prior art keywords
remedies
agents against
against gravity
prevention agents
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69928685T
Other languages
English (en)
Other versions
DE69928685T2 (de
Inventor
Masaaki Goto
Akihiro Tomoyasu
Kyoji Yamaguchi
Masahiko Kinosaki
Nobuaki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69928685D1 publication Critical patent/DE69928685D1/de
Publication of DE69928685T2 publication Critical patent/DE69928685T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lubricants (AREA)
  • Seal Device For Vehicle (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69928685T 1998-09-17 1999-09-17 Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit Expired - Fee Related DE69928685T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26300498 1998-09-17
JP26300498 1998-09-17
PCT/JP1999/005080 WO2000016795A1 (en) 1998-09-17 1999-09-17 Preventives and/or remedies for obesity

Publications (2)

Publication Number Publication Date
DE69928685D1 true DE69928685D1 (de) 2006-01-05
DE69928685T2 DE69928685T2 (de) 2006-08-24

Family

ID=17383564

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69928685T Expired - Fee Related DE69928685T2 (de) 1998-09-17 1999-09-17 Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit

Country Status (7)

Country Link
US (1) US6815417B1 (de)
EP (1) EP1121936B1 (de)
AT (1) ATE311197T1 (de)
AU (1) AU759409B2 (de)
CA (1) CA2342834A1 (de)
DE (1) DE69928685T2 (de)
WO (1) WO2000016795A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
US8569240B2 (en) 2008-01-25 2013-10-29 Regeron, Inc. Methods of preventing or treating brain diseases
KR20090082154A (ko) * 2008-01-25 2009-07-29 주식회사 리제론 뇌질환의 예방 또는 치료용 조성물
JP5946191B2 (ja) 2011-07-09 2016-07-05 国立大学法人東北大学 線維症予防又は治療用医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003949A1 (en) * 1986-11-21 1988-06-02 Howard Florey Institute Of Experimental Physiology The cs protein of the corpuscles of stannius
US5837498A (en) 1994-03-08 1998-11-17 Human Genome Scienes, Inc. Corpuscles of stannius protein, stanniocalcin

Also Published As

Publication number Publication date
EP1121936A1 (de) 2001-08-08
EP1121936A4 (de) 2004-11-17
DE69928685T2 (de) 2006-08-24
AU5653299A (en) 2000-04-10
EP1121936B1 (de) 2005-11-30
CA2342834A1 (en) 2000-03-30
WO2000016795A1 (en) 2000-03-30
AU759409B2 (en) 2003-04-17
US6815417B1 (en) 2004-11-09
ATE311197T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
ATE297204T1 (de) Heilmittel für neurodegenerative krankheiten
ATE177949T1 (de) Kombinationstherapie zur prophylaxe und/oder behandlung benigner prostatahyperplasie
GB0225475D0 (en) Therapeutic agents
BR9912805A (pt) Composições farmacêuticas para a prevenção e para o tratamento de distúrbios do sistema nervoso central
DE69732170D1 (de) Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan
GB0223040D0 (en) Therapeutic compounds
BG106450A (en) Use of retigabin for treating neuropathic pain
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
EP1232757A4 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
DE60016460D1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
WO2004038001A3 (en) Substituted tetracycline compounds for the treatment of malaria
DE60002226D1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte
BG105962A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
DE69928685D1 (de) Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit
TR200103418T2 (tr) Melatoninin tedavi edici kullanımı.
CZ20011550A3 (cs) Opticky aktivní derivát pyridyl-4H-1,2,4-oxadiazinu, jeho použití při léčbě vaskulárních onemocnění a farmaceutické kompozice ho obsahující
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
ATE469642T1 (de) Vorbeugungs- oder heilmittel gegen endometriose
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
BR0116554A (pt) Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
ATE223212T1 (de) Conagenine zur prävention und behandlung von diarrhöe
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee